You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
A股異動丨廣譽遠(600771.SH)漲超5% “神藥”安宮牛黃丸再提價 近1000元/粒
格隆匯 03-09 10:14
格隆匯3月9日丨廣譽遠(600771.SH)漲超5%,報32.45元,總市值160億元。近日,一份名為“關於精品安宮牛黃丸定價的通知”的文件在業內流傳,文件下方的印章為山西廣譽遠國藥有限公司。文件指出,根據原材料價格及產品工藝特性,經綜合評估,決定對精品安宮牛黃丸定價為,安宮牛黃丸(雙天然鐵盒3g丸×1丸/盒×6盒)5880元/盒,安宮牛黃丸(雙天然木盒3g丸×1丸/盒×2盒)3360元/盒,安宮牛黃丸(雙天然木盒3g丸×1丸/盒×6盒)10080元/盒。此價格於4月1日起執行。目前,生產安宮牛黃丸的企業有同仁堂、九芝堂、華潤三九、廣譽遠、片仔癀等。據傳,這藥對預防中風、中風預後都有療效,就連吃藥時間也有講究,一定要驚蟄當天11點吃。值得注意的是,1月29日,廣譽遠發佈2021年度業績預虧預吿,2021年全年公司歸母淨利潤虧損3.3億元,同比下降1131.15%。頻繁漲價的背後或許是以提價的方式來拯救虧損的業績。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account